![Ajim Tamboli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ajim Tamboli
Plus aucun poste en cours
Profil
Ajim Akbar Tamboli is currently Chief Financial Officer at First Tracks Biotherapeutics, Inc. since 2026.
Formerly, served as Chief Financial Officer at Monte Rosa Therapeutics, Inc. from 2020 to 2023, at Rodin Therapeutics, Inc. from 2019 to 2020, and at ADARx Pharmaceuticals, Inc. Held the position of Analyst at Asymmetry Capital Management LP from 2018 to 2019 and at Columbia Management Investment Advisers LLC from 2010 to 2013.
Worked as Senior Portfolio Manager at Hovan Capital Management LLC from 2008 to 2009.
Was Research Analyst at Lehman Brothers, Inc. from 2003 to 2007 and Consultant at Duquesne Capital Management LLC in 2002.
Served as Equity Research Analyst at Credit Suisse Securities (USA) LLC (Broker) from 2000 to 2001.
Also held the role of Partner & Analyst at Endurant Capital Management LP.
Education includes undergraduate degree in 1998 and graduate degree in 2002 from the University of Pennsylvania.
Postes actifs de Ajim Tamboli
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Ajim Tamboli
| Sociétés | Poste | Fin |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Directeur Financier/CFO | 08/08/2023 |
Rodin Therapeutics, Inc.
 Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Directeur Financier/CFO | 01/01/2020 |
Asymmetry Capital Management LP
 Asymmetry Capital Management LP Investment ManagersFinance Asymmetry Capital Management seeks to deliver absolute, risk-adjusted returns across market cycles by investing in a value-oriented, diversified, global portfolio of healthcare companies. The firm's objective is to generate returns on both long and short positions with moderate to low net exposure and low correlations to broad equity and healthcare-related indices. Asymmetry also focuses on maximizing positive and sustainable impacts on ESG (environment, social and governance) and responsible investing. | Analyst-Equity | 01/01/2019 |
Columbia Management Investment Advisers LLC
 Columbia Management Investment Advisers LLC Investment ManagersFinance CMIA manages no-load mutual funds and separate client-focused equity, fixed-income and balanced portfolios. The firm invests in the growth and value stocks of small-cap, mid-cap and large-cap domestic and international companies. Their investment strategy combines a top-down approach and thematic and fundamental analysis with a bottom-up stock selection process. CMIA’s fixed-income investments focus on short-term, intermediate-term and long-term high-quality debt instruments including US Treasuries, MBS, ABS, municipal bonds and agency bonds. Their balanced investment approach is a blend of their equity and debt strategies. Portfolios are benchmarked against the S&P 500 Index and the Barclays Capital Aggregate Index (formerly the Lehman Aggregate Index). | Analyst-Equity | 01/07/2013 |
Hovan Capital Management LLC
 Hovan Capital Management LLC Investment ManagersFinance Hovan Capital Management invests primarily in the stocks of US small-cap companies in the health technology, biotechnology and electronic technology sectors. | Analyst-Equity | 01/12/2009 |
Formation de Ajim Tamboli
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Duquesne Capital Management LLC
 Duquesne Capital Management LLC Investment ManagersFinance Duquesne Capital Management is a top-down manager that invests in growth-oriented value stocks. The firm looks for market leaders and turnaround stocks. They focus primarily on investments in the stocks of mid-cap and large-cap US companies in the energy minerals, process industries, health technology and electronic technology sectors. Duquesne Capital Management maintains a very high turnover rate. | Finance |
Hovan Capital Management LLC
Hovan Capital Management LLC Investment ManagersFinance Hovan Capital Management invests primarily in the stocks of US small-cap companies in the health technology, biotechnology and electronic technology sectors. | Finance |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Management Investment Advisers LLC
Columbia Management Investment Advisers LLC Investment ManagersFinance CMIA manages no-load mutual funds and separate client-focused equity, fixed-income and balanced portfolios. The firm invests in the growth and value stocks of small-cap, mid-cap and large-cap domestic and international companies. Their investment strategy combines a top-down approach and thematic and fundamental analysis with a bottom-up stock selection process. CMIA’s fixed-income investments focus on short-term, intermediate-term and long-term high-quality debt instruments including US Treasuries, MBS, ABS, municipal bonds and agency bonds. Their balanced investment approach is a blend of their equity and debt strategies. Portfolios are benchmarked against the S&P 500 Index and the Barclays Capital Aggregate Index (formerly the Lehman Aggregate Index). | Finance |
Rodin Therapeutics, Inc.
Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Endurant Capital Management LP
 Endurant Capital Management LP Investment ManagersFinance Endurant Capital seeks to generate steady, risk-adjusted returns through long/short investments of small- to mid-cap growth companies in the healthcare sector. The firm’s fund and sub-advised accounts invest principally, but not solely, in equity and equity-related securities that are traded publicly in US markets. | Finance |
Asymmetry Capital Management LP
Asymmetry Capital Management LP Investment ManagersFinance Asymmetry Capital Management seeks to deliver absolute, risk-adjusted returns across market cycles by investing in a value-oriented, diversified, global portfolio of healthcare companies. The firm's objective is to generate returns on both long and short positions with moderate to low net exposure and low correlations to broad equity and healthcare-related indices. Asymmetry also focuses on maximizing positive and sustainable impacts on ESG (environment, social and governance) and responsible investing. | Finance |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
Monte Rosa Therapeutics, Inc.
 Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
